Explore the unique perspective of a man living with progressive blindness as he details the five distinct stages of his sight ...
Good morning, and welcome to Ocugen's Webcast to discuss the Top Line 12-month Results from Phase II ArMaDa Clinical Trial Evaluating OCU410 for Geographic Atrophy or GA Secondary to Dry Age-related ...
Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth (31%) versus control at 12 months (p< ...
Learning to adapt to life with geographic atrophy (GA), one woman finds new ways to stay true to her adventurous spirit ...
Discover the latest breakthroughs in the fight against dry, age-related macular degeneration. Learn about the first approved ...
There are two types of macular degeneration: dry and wet. Dry age-related macular degeneration is the most common type — it ...
1d
Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting
Strengthening Capital Structure and Advancing Clinical Development StrategyPalm Beach Gardens, FL, March 23, 2026 (GLOBE NEWSWIRE) -- Curative ...
Discover more about how a common diabetes drug can reduce the incidence of intermediate age-related macular degeneration.
Carotenoids like beta-carotene, lycopene, lutein, and zeaxanthin may improve skin, heart, and bone health or prevent prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results